Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Ibara will drive AI-powered clinical research innovation
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
EDQM has also issued a Certificate of Suitability for Allopurino
Subscribe To Our Newsletter & Stay Updated
